Related Experiment Videos
Prospects for DNA-based prenatal diagnosis of mitochondrial disorders
1Department of Paediatrics, John Radcliffe Hospital, Headington, Oxford, U.K.
Abstract:
Mitochondria have their own DNA which is maternally inherited. Mitochondrial DNA (mtDNA) diseases are extremely variable because of the genetics of mtDNA and the unique pathogenesis of these disorders. This makes predicting the prognosis and the transmission of mtDNA disorders difficult. While mtDNA polymorphisms at a single base position are common, the overwhelming majority of the mitochondrial genomes within a single human individual are usually identical. When there is a point mutation difference between a mother and her offspring, there may be a complete switching of mtDNA type within a single generation. It is generally assumed that there is a genetic bottleneck whereby a single or small number of founder mtDNA(s) populate the organism, but it is not known at which stages the restriction/amplification of mtDNA subtype(s) occur, and this uncertainty impedes antenatal diagnosis for mtDNA disorders. Autosomally inherited disorders of mitochondrial function may be caused by mutations in genes for the components of the respiratory chain and for the machinery of mitochondrial biogenesis, which are nuclear-encoded. Accurate diagnosis of these disorders is important as prenatal diagnosis is available in a minority of cases.
Insights
Mitochondrial DNA (mtDNA) diseases present diagnostic challenges due to their variable inheritance and pathogenesis. Understanding the genetic bottleneck is crucial for improving prenatal diagnosis of these complex inherited disorders.
Area of Science:
- Genetics
- Molecular Biology
- Mitochondrial Biology
Background:
- Mitochondria possess their own DNA (mtDNA), which is maternally inherited.
- Mitochondrial DNA diseases exhibit significant variability due to mtDNA genetics and unique disease mechanisms, complicating prognosis and transmission prediction.
- While mtDNA polymorphisms are common, individuals typically have a near-uniform mitochondrial genome, with potential for rapid shifts in mtDNA type between generations.
Purpose of the Study:
- To highlight the difficulties in predicting prognosis and transmission of mitochondrial DNA (mtDNA) disorders.
- To address the uncertainty surrounding the genetic bottleneck and its role in mtDNA subtype restriction/amplification.
- To emphasize the importance of accurate diagnosis for both maternally inherited and nuclear-encoded mitochondrial disorders, particularly concerning prenatal diagnosis availability.
Main Methods:
- Review of existing literature on mitochondrial DNA genetics and disease pathogenesis.
- Analysis of mtDNA inheritance patterns and variability within and between generations.
- Discussion of diagnostic challenges and implications for prenatal testing.
Main Results:
- Mitochondrial DNA (mtDNA) diseases are characterized by extreme variability, making prognosis and transmission prediction difficult.
- The precise mechanisms and timing of the genetic bottleneck in mtDNA inheritance remain unclear, hindering antenatal diagnosis.
- Nuclear-encoded mitochondrial disorders, while diagnosable, have limited prenatal diagnostic options.
Conclusions:
- The complex genetics and pathogenesis of mitochondrial DNA (mtDNA) disorders impede accurate prediction and diagnosis.
- Further research into the genetic bottleneck is essential for advancing antenatal diagnosis of mtDNA-related diseases.
- Accurate diagnosis is critical for both mtDNA and nuclear-encoded mitochondrial disorders, especially given the limited availability of prenatal testing.